Divergent kinase signaling mediates agonist-induced phosphorylation of phosphatase inhibitory proteins PHI-1 and CPI-17 in vascular smooth muscle cells

American Journal of Physiology - Cell Physiology

Volumn 290, Issue 3, 2006, Pages

  Pang, Huan ^a   Guo, Zhenheng ^a   Xie, Zhongwen ^a   Su, Wen ^a   Gong, Ming C ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Myosin phosphatase holoenzyme inhibitor 1; Protein kinase C; Signal transduction

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; ANGIOTENSIN II; CPI 17; PHOSPHATASE HOLOENZYME INHIBITOR; PHOSPHOPROTEIN PHOSPHATASE INHIBITOR; RHO KINASE; THROMBIN; UNCLASSIFIED DRUG; MUSCLE PROTEIN; PHOSPHOPROTEIN; PHOSPHOPROTEIN PHOSPHATASE INHIBITOR 1; PPP1R14A PROTEIN, RAT; PROTEIN; PROTEIN SERINE THREONINE KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG INHIBITION; ENZYME ACTIVATION; ENZYME INHIBITION; IMMUNOBLOTTING; ISOELECTRIC POINT; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SMOOTH MUSCLE FIBER; ANIMAL; CYTOLOGY; DRUG EFFECT; DRUG POTENTIATION; ENZYMOLOGY; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT; VASCULAR SMOOTH MUSCLE;

ANIMALIA;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ANGIOTENSIN II; ANIMALS; MUSCLE PROTEINS; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; THROMBIN;

EID: 33645457167     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00378.2005     Document Type: Article

References (35)

1. 2+ sensitization in smooth muscle. J Biol Chem 279: 28998-29003, 2004.
2. Deng JT, Sutherland C, Brautigan DL, Eto M, and Walsh MP. Phosphorylation of the myosin phosphatase inhibitors, CPI-17 and PHI-1, by integrin-linked kinase. Biochem J 367: 517-524, 2002.
3. El-Touhky A, Given AM, Cochard A, and Brozovich FV. PHI-1 induced enhancement of myosin phosphorylation in chicken smooth muscle. FEBS Lett 579: 4271-4277, 2005.
4. Eto M, Bock R, Brautigan DL, and Linden DJ. Cerebellar long-term synaptic depression requires PKC-mediated activation of CPI-17, a myosin/moesin phosphatase inhibitor. Neuron 36: 1145-1158, 2002.
5. Eto M, Karginov A, and Brautigan DL. A novel phosphoprotein inhibitor of protein type-1 phosphatase holoenzymes. Biochemistry 38: 16952-16957, 1999.
6. Eto M, Kitazawa T, and Brautigan DL. Phosphoprotein inhibitor CPI-17 specificity depends on allosteric regulation of protein phosphatase-1 by regulatory subunits. Proc Natl Acad Sci USA 101: 8888-8893, 2004.
7. Eto M, Kitazawa T, Yazawa M, Mukai H, Ono Y, and Brautigan DL. Histamine-induced vasoconstriction involves phosphorylation of a specific inhibitor protein for myosin phosphatase by protein kinase C α and δ isoforms. J Biol Chem 276: 29072-29078, 2001.
8. Eto M, Ohmori T, Suzuki M, Furuya K, and Morita F. A novel protein phosphatase-1 inhibitory protein potentiated by protein kinase C. Isolation from porcine aorta media and characterization. J Biochem (Tokyo) 118: 1104-1107, 1995.
9. Eto M, Wong L, Yazawa M, and Brautigan DL. Inhibition of myosin/moesin phosphatase by expression of the phosphoinhibitor protein CPI-17 alters microfilament organization and retards cell spreading. Cell Motil Cytoskeleton 46: 222-234, 2000.
10. Etter EF, Eto M, Wardle RL, Brautigan DL, and Murphy RA. Activation of myosin light chain phosphatase in intact arterial smooth muscle during nitric oxide-induced relaxation. J Biol Chem 276: 34681-34685, 2001.
11. 2+ sensitization of contraction in vascular smooth muscle. J Biol Chem 278: 1856-1863, 2003.
12. Hartshorne DJ. Biochemistry of the contractile process in smooth muscle. In: Physiology of the Gastrointestinal Tract (2nd ed.), edited by Johnson LR. New York: Raven, 1987, p. 423-482.
13. Ito M, Nakano T, Erdodi F, and Hartshorne DJ. Myosin phosphatase: structure, regulation and function. Mol Cell Biochem 259: 197-209, 2004.
14. 2+ sensitization of myosin light chain phosphorylation in smooth muscle. Biochem J 318: 469-475, 1996.
15. Kandabashi T, Shimokawa H, Miyata K, Kunihiro I, Kawano Y, Fukata Y, Higo T, Egashira K, Takahashi S, Kaibuchi K, and Takeshita A. Inhibition of myosin phosphatase by upregulated rho-kinase plays a key role for coronary artery spasm in a porcine model with interleukin-1β. Circulation 101: 1319-1323, 2000.
16. Kitazawa T, Eto M, Woodsome TP, and Brautigan DL. Agonists trigger G protein-mediated activation of the CPI-17 inhibitor phosphoprotein of myosin light chain phosphatase to enhance vascular smooth muscle contractility. J Biol Chem 275: 9897-9900, 2000.
17. 2+ sensitization in rabbit smooth muscle. J Physiol 546: 879-889, 2003.
18. Kitazawa T, Masuo M, and Somlyo AP. G protein-mediated inhibition of myosin light-chain phosphatase in vascular smooth muscle. Proc Natl Acad Sci USA 88: 9307-9310, 1991.
19. Kitazawa T, Polzin AN, and Eto M. CPI-17-deficient smooth muscle of chicken. J Physiol 557: 515-528, 2004.
20. Morishige K, Shimokawa H, Eto Y, Kandabashi T, Miyata K, Matsumoto Y, Hoshijima M, Kaibuchi K, and Takeshita A. Adenovirus-mediated transfer of dominant-negative rho-kinase induces a regression of coronary arteriosclerosis in pigs in vivo. Arterioscler Thromb Vasc Biol 21: 548-554, 2001.
21. Murthy KS, Zhou H, Grider JR, Brautigan DL, Eto M, and Makhlouf GM. Differential signalling by muscarinic receptors in smooth muscle: m2-mediated inactivation of myosin light chain kinase via Gi3, Cdc42/Rac1 and p21-activated kinase 1 pathway, and m3-mediated MLC20 (20 kDa regulatory light chain of myosin II) phosphorylation via Rho-associated kinase/myosin phosphatase targeting subunit 1 and protein kinase C/CPI-17 pathway. Biochem J 374: 145-155, 2003.
22. Ohama T, Hori M, Sato K, Ozaki H, and Karaki H. Chronic treatment with interleukin-1β attenuates contractions by decreasing the activities of CPI-17 and MYPT-1 in intestinal smooth muscle. J Biol Chem 278: 48794-48804, 2003.
23. Pang H, Guo Z, Su W, Xie Z, Eto M, and Gong MC. RhoA-Rho kinase pathway mediates thrombin- and U-46619-induced phosphorylation of a myosin phosphatase inhibitor, CPI-17, in vascular smooth muscle cells. Am J Physiol Cell Physiol 289: C352-C360, 2005.
24. Pauly RR, Bilato C, Cheng L, Monticone R, and Crow MT. Vascular smooth muscle cell cultures. Methods Cell Biol 52: 133-154, 1997.
25. Seko T, Ito M, Kureishi Y, Okamoto R, Moriki N, Onishi K, Isaka N, Hartshorne DJ, and Nakano T. Activation of RhoA and inhibition of myosin phosphatase as important components in hypertension in vascular smooth muscle. Circ Res 92: 411-418, 2003.
26. Shimokawa H, Seto M, Katsumata N, Amano M, Kozai T, Yamawaki T, Kuwata K, Kandabashi T, Egashira K, Ikegaki I, Asano T, Kaibuchi K, and Takeshita A. Rho-kinase-mediated pathway induces enhanced myosin light chain phosphorylations in a swine model of coronary artery spasm. Cardiovasc Res 43: 1029-1039, 1999.
27. 2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase. Physiol Rev 83: 1325-1358, 2003.
28. Somlyo AP and Somlyo AV. Signal transduction and regulation in smooth muscle. Nature 372: 231-236, 1994.
29. 2+-sensitization of chicken amnion smooth muscle lacking CPI-17. FEBS Lett 578: 73-79, 2004.
30. Tountas NA and Brautigan DL. Migration and retraction of endothelial and epithelial cells require PHI-1, a specific protein-phosphatase-1 inhibitor protein. J Cell Sci 117: 5905-5912, 2004.
31. Tountas NA, Mandell JW, Everett AD, and Brautigan DL. Juxtamembrane localization of the protein phosphatase-1 inhibitor protein PHI-1 in smooth muscle cells. Histochem Cell Biol 121: 343-350, 2004.
32. Uehata M, Ishizaki T, Satoh H, Ono T, Kawahara T, Morishita T, Tamakawa H, Yamagami K, Inui J, Maekawa M, and Narumiya S. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 389: 990-994, 1997.
33. Walker LA, Gailly P, Jensen PE, Somlyo AV, and Somlyo AP. The unimportance of being (protein kinase C) epsilon. FASEB J 12: 813-821, 1998.
34. 2+ sensitization in erectile function. J Biol Chem 277: 30614-30621, 2002.
35. 2+ sensitivity of protein kinase C-induced contraction in rabbit smooth muscle. J Physiol 535: 553-564, 2001.